,
Loeffler-Wirth, Henry http://orcid.org/0000-0001-8239-440X
Kreuz, Markus
Hopp, Lydia
Arakelyan, Arsen
Haake, Andrea
Cogliatti, Sergio B.
Feller, Alfred C.
Hansmann, Martin-Leo
Lenze, Dido
Möller, Peter
Müller-Hermelink, Hans Konrad
Fortenbacher, Erik
Willscher, Edith
Ott, German
Rosenwald, Andreas
Pott, Christiane
Schwaenen, Carsten
Trautmann, Heiko
Wessendorf, Swen
Stein, Harald
Szczepanowski, Monika
Trümper, Lorenz
Hummel, Michael
Klapper, Wolfram
Siebert, Reiner
Loeffler, Markus
Binder, Hans
Funding for this research was provided by:
Deutsche Krebshilfe (70-3173-Tr3)
Bundesministerium für Bildung und Forschung (031 6166)
Bundesministerium für Bildung und Forschung (031 5452A, WTZ ARM II-010, FFE-0034)
Article History
Received: 9 November 2018
Accepted: 4 April 2019
First Online: 30 April 2019
Ethics approval and consent to participate
: The study was performed as part of the ‘Molecular Mechanisms in Malignant Lymphomas’ Network Project of the Deutsche Krebshilfe for which central (University Hospital, Göttingen), and local ethics approval was obtained. Informed consent was obtained in accordance with the Declaration of Helsinki.
: Not applicable.
: The authors declare that they have no competing interests. Dido Lenze (now affiliated with AstraZeneca) contributed to the MMML consortium during her employment at Charité Universitätsmedizin, Berlin.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.